The Paul Langerhans Institute Dresden

Over the last few decades, diabetes mellitus has developed into an epidemic dimension. More and more people around the world suffer from this metabolic disease and its consequences, and even children and young people in the industrial nations are increasingly affected.

The Paul Langerhans Institute of the Helmholtz Zentrum München at the University Hospital Carl Gustav Carus and the Medical Faculty of TU Dresden (PLID) contributes decisively to a better understanding of the mechanisms of the disease and to explore new therapeutic options. The institute is a founding-partner of the German Center for Diabetes Research (DZD e.V.) and has been a satellite institute of Helmholtz Munich since January 2015. Working in the DZD network allows research projects of a much larger scale, both in the area of basic research through interdisciplinary approaches as well as in the area of clinical studies.

With the founding of the DZD in 2009, the German government created a national research association which aims to bring research results more quickly to clinical practice. To this end, it brings together experts in the field of diabetes research, so that basic research, epidemiology, translational research and clinical application can closely interact and successful research as well as effective prevention and treatment measures can be realized.

You will find more information about our scientific work under Research.